More significantly, our data pointed out that PAMAMs induce upregulation of JNK1/2/3 and downregulation of phosphorylated Erk1/Erk2 in both HER2-positive cancer-treated cells in comparison with their control (Fig. 7). The gene discussed is MAPK3; the disease is cancer.